About
Technology
Issues
FAQ
Links
Official Page
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.